ONCAlert | Upfront Therapy for mRCC
News
Using Select Assessment Criteria May Change Prognoses in Advanced HCC
9:00 PM, Fri October 18, 2019
Frontline Ivosidenib/Azacitidine Combo Shows Early Promising Efficacy in IDH1+ AML
8:19 PM, Fri October 18, 2019
Abemaciclib Triplet Prolongs PFS in HR+/HER2+ Breast Cancer
6:00 PM, Fri October 18, 2019
Osimertinib/Cetuximab Inhibits Tumor Growth in EGFR-Mutant NSCLC
4:17 PM, Fri October 18, 2019
FDA Approves Romiplostim for Earlier Use in Adults With ITP
2:56 PM, Fri October 18, 2019
Challenges Remain in Hepatocellular Carcinoma Surveillance of Patients With NASH
7:33 PM, Thu October 17, 2019
FDA Grants Priority Review of DS-8201 for HER2+ Metastatic Breast Cancer
4:52 PM, Thu October 17, 2019
Langer Highlights the Potential Benefits of Postchemoradiation Immunotherapy in NSCLC
4:23 PM, Thu October 17, 2019
